Table 1 Clinical features and treatment of BD patients at the time of the study and cumulative

Clinical features: N = 23

 Disease duration in years (mean ± SD)

15 ± 8

-

 Deep vein thrombosis (%)

0

4

 Disease activity, median (p25-p75)

7 (2–18)

-

 Patients on active phase of disease (%)

78

-

 Genital ulcer (%)

13

97

 Oral ulcer (%)

52

100

 Skin lesion (%)

43

90

 Vascular involvement (%)

0

21

 Articular involvement (%)

43

67

 Gastrointestinal involvement (%)

30

32

 Ocular involvement (%)

22

64

 Neurological involvement (%)

43

72

Treatments:

 Prednisone (< 10 mg) (%)

9

83

 Prednisone (> 10 mg) (%)

18

87

 Cyclosporine (%)

4

18

 Azathioprine (%)

9

32

 Methotrexate (%)

4

7

 Infliximab (%)

4

3

 Rituximab (%)

4

7

 Colchicine (%)

17

86